CVE-2017-5149
What it is
An issue was discovered in St. Jude Medical Merlin@home, versions prior to Version 8.2.2 (RF models: EX1150; Inductive models: EX1100; and Inductive models: EX1100 with MerlinOnDemand capability). The identities of the endpoints for the communication channel between the transmitter and St. Jude Medical's web site, Merlin.net, are not verified. This may allow a man-in-the-middle attacker to access or influence communications between the identified endpoints.
At a glance
- Exploitability
- Can be exploited over the network without logging in. High risk of data tampering, service disruption.
- Exploit odds
- 1.2% chance of exploitation in the next 30 days (EPSS).
- Fix
- A patch, advisory or fixed version is referenced. Upgrade or apply it.
Timeline
- PublishedDisclosed publicly on CVE.org and NVD
- Last updatedMost recent change to the record
Why it ranks here
- Exploited in the wild: no, CISA does not list it.
- Exploit odds: 1.2% in the next 30 days (EPSS).
- Severity: 8.9 HIGH (CVSS).
- Fix: a patch or advisory is linked.
Details
- Published
- Last modified
- Exploit probability
- 1.2% · EPSS, next 30 days
- Weakness
- CWE-476 · NULL pointer dereference
- Record status
- Modified
Affected
- Abbott merlin\@home Firmware ≤ 8.0
Attack profile CVSS 3.1 · 8.9
- Attack vector
- Network
- Complexity
- High
- Privileges needed
- None
- User interaction
- None
- Scope
- Changed
- Confidentiality
- Low
- Integrity
- High
- Availability
- High
Raw vector
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:L/I:H/A:H
Is it in your code?
Hand this to your coding agent. It searches your project for the affected products and checks versions. Nothing leaves your machine.
Read https://cve-list.com/agent/cve/CVE-2017-5149.md and follow it. Check whether this project is affected by CVE-2017-5149. Read only. Don't change anything and don't upload my code. Tell me yes, no or not sure, with the file as proof.
Fix and advisories
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-009-01A
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-009-01A